CVR Medical Corp. (CRRVF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.91: the stock has moved about 91% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCVR Medical Corp. (CRRVF) trades at $0.00001. CVR Medical Corp. is a North Vancouver-based healthcare company specializing in advanced acoustic wave analysis technology for medical diagnostics. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for CRRVF: CRRVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CVR Medical Corp. (CRRVF) Healthcare & Pipeline Overview
CVR Medical Corp. leverages innovative acoustic wave analysis technology to enhance diagnostic accuracy in cardiovascular health, addressing a critical need in the healthcare sector for early detection and intervention.
What Is the Investment Thesis for CRRVF?
CVR Medical Corp. presents a unique investment thesis driven by its proprietary carotid stenotic scan device, which addresses a critical market need for early detection of cardiovascular diseases. The global market for cardiovascular diagnostics is projected to grow significantly, with estimates suggesting a CAGR of over 7% through 2030. The company’s focus on advanced acoustic wave analysis technology provides a competitive edge, particularly in non-invasive diagnostics. However, investors should remain aware of the risks associated with regulatory approvals and the challenges of operating as an OTC Other listed company, which may affect liquidity and information availability. Monitoring clinical trial outcomes and market acceptance will be crucial for assessing the company’s growth trajectory.
Based on FMP financials and quantitative analysis
CRRVF Key Highlights
Market Cap: $0.00B, indicating a current lack of market valuation.
- Beta: 1.91, suggesting higher volatility compared to the market.
- Dividend Yield: None, as the company does not currently pay dividends.
- Focus on non-invasive diagnostics, a growing segment in the healthcare industry.
- Established in 1980, indicating over 40 years of experience in the medical technology sector.
Who Are CRRVF's Competitors?
CRRVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MDT Medtronic plc | $87.97 | +1.84% | $113B | 80 5-pillar |
| SYK Stryker Corporation | $285.22 | +3.55% | $109B | 79 5-pillar |
| ABT Abbott Laboratories | $100.10 | +2.67% | $173B | 70 5-pillar |
| BJDX Bluejay Diagnostics, Inc. | $0.76 | -9.01% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.01 | -1.11% | $5.63M | 30 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.74 | -1.09% | $31.4M | — |
| SNWV SANUWAVE Health, Inc. | $4.70 | -2.49% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.92 | -2.01% | $48.1M | 31 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CRRVF's Key Strengths?
Innovative technology focused on non-invasive diagnostics.
- Strong emphasis on research and development capabilities.
- Established presence in the healthcare industry since 1980.
What Are CRRVF's Weaknesses?
Limited financial resources as indicated by a market cap of $0.00B.
- Higher risks associated with being an OTC Other listed company.
- Potential challenges in scaling operations and production.
What Are the Key Risks for CRRVF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory hurdles that could delay product launches.
- Market competition from established medical device companies.
- Risks associated with being an OTC Other listed company, including liquidity issues.
What Are CRRVF's Competitive Advantages?
- Proprietary technology in acoustic wave analysis for medical diagnostics.
- Focus on non-invasive procedures, enhancing patient comfort and compliance.
- Established brand presence with over 40 years in the healthcare sector.
What Does CRRVF Do?
Established in 1980 and headquartered in North Vancouver, Canada, CVR Medical Corp. has carved a niche in the healthcare sector by focusing on the research and development of advanced acoustic wave analysis technologies. The company's flagship product, the carotid stenotic scan device, is engineered to accurately identify and quantify narrowing within the carotid arteries, which is crucial for assessing the risk of stroke and other cardiovascular diseases. This innovative technology not only aids patients but also serves insurance providers and medical professionals by facilitating timely diagnoses and treatment plans. Over the years, CVR Medical has evolved from a research-focused entity to a more product-oriented company, emphasizing the commercialization of its proprietary technologies. The carotid stenotic scan device represents a significant advancement in non-invasive diagnostic tools, positioning CVR Medical as a key player in the medical device industry. With a growing emphasis on preventative healthcare and early disease detection, CVR Medical is well-positioned to meet the increasing demand for innovative diagnostic solutions in cardiovascular health.
What Products and Services Does CRRVF Offer?
- Develop advanced acoustic wave analysis technology for medical applications.
- Create diagnostic instruments for identifying cardiovascular diseases.
- Focus on non-invasive techniques to improve patient comfort and outcomes.
- Target healthcare providers, insurance companies, and patients with innovative solutions.
- Conduct research and development to enhance existing medical technologies.
- Aim to improve early detection and treatment of carotid artery diseases.
How Does CRRVF Make Money?
- Generate revenue through the sale of diagnostic devices and technologies.
- Partner with healthcare providers for product integration and usage.
- Explore licensing agreements for proprietary technology.
- Focus on research grants and funding for ongoing development projects.
What Industry Does CRRVF Operate In?
The medical devices industry is experiencing robust growth, driven by increasing healthcare expenditures and a rising focus on preventative care. The global cardiovascular diagnostics market is expanding, with a projected size of over $20 billion by 2030, reflecting a growing demand for innovative diagnostic solutions. CVR Medical Corp. operates within this competitive landscape, where rapid technological advancements and regulatory changes are common. The company’s emphasis on non-invasive diagnostic tools positions it favorably against traditional methods, appealing to both healthcare providers and patients seeking safer and more efficient diagnostic options.
Who Are CRRVF's Key Customers?
- Healthcare providers looking for advanced diagnostic tools.
- Insurance companies interested in cost-effective healthcare solutions.
- Patients requiring non-invasive assessments of cardiovascular health.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for CVR Medical Corp. stands at 50.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
CVR Medical Corp. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in North Vancouver, CA. The company is led by CEO Darren Day. CRRVF has traded publicly since 2016.
Financial Health
CVR Medical Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CRRVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
CRRVF Latest News
No recent news available for CRRVF.
CRRVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CRRVF.
Price Targets
Wall Street price target analysis for CRRVF.
CRRVF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CRRVF; grades run from A+ (80-100) to F (below 30).
Leadership: Darren Day
CEO
Darren Day has a diverse background in healthcare management and technology innovation. He has held various leadership roles in medical technology companies, focusing on product development and market strategy. With a strong educational foundation in biomedical engineering and business administration, Darren brings a wealth of knowledge to CVR Medical Corp.
Track Record: Under Darren's leadership, CVR Medical has made significant strides in developing its carotid stenotic scan device, positioning the company for potential growth in the cardiovascular diagnostics market. His strategic vision has been instrumental in navigating the challenges of the healthcare landscape.
CRRVF OTC Market Information
The OTC Other tier includes companies that do not meet the criteria for higher tiers like OTCQX or OTCQB, often resulting in less stringent reporting requirements. This may lead to lower liquidity and increased risks for investors due to limited information availability.
- OTC Tier: OTC Other
- Higher volatility and risk associated with OTC stocks.
- Limited financial disclosure may hinder informed investment decisions.
- Potential for lower investor interest and trading volume.
- Verify the company's financial health through available reports.
- Assess the regulatory status of the carotid stenotic scan device.
- Research the competitive landscape and market positioning.
- Evaluate the management team's track record and expertise.
- Monitor upcoming clinical trials and product approvals.
- Established company with over 40 years in the healthcare sector.
- Focus on innovative medical technology with potential market impact.
- Engagement in research and development to enhance product offerings.
What Investors Ask About CVR Medical Corp. (CRRVF) — Healthcare
What are the main risks for CRRVF?
CVR Medical Corp. faces several risks, including regulatory hurdles that could delay product approvals and market entry. As an OTC Other listed company, it also experiences higher volatility and liquidity risks, which may affect trading and investment decisions.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The company's financial status is currently limited due to its OTC classification.